Inventor · disambiguated record
Michael D. Meyer
Also filed as: MEYER MICHAEL · MEYER MICHAEL D
20 granted patents·3 pending applications·379 citations·filing 1989–2021
95Inventor score
Top patents by PatentIndex Score
23 records- 0193US5049564A5-HT selective agentsABBOTT LAB·Filed 1989·Granted Sep 17, 1991·42 cites·7 claims
- 0292US7750039B2Indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2009·Granted Jul 6, 2010·17 cites·5 claims
- 0391US7560481B2Indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2005·Granted Jul 14, 2009·17 cites·14 claims
- 0487US6046207ABenzopyranopyrrole and benzopyranopyridine α-1 adrenergic compoundsFiled 1997·Granted Apr 4, 2000·37 cites·4 claims
- 0587US4963568ADopamine agonistsABBOTT LAB·Filed 1989·Granted Oct 16, 1990·52 cites·8 claims
- 0684US8481574B2Compounds as cannabinoid receptor ligandsMEYER MICHAEL D·Filed 2007·Granted Jul 9, 2013·17 cites·15 claims
- 0784US5891882ABenzopyranopyrrole and benzopyranopyridine α-1 adenergic compoundsABBOTT LAB·Filed 1997·Granted Apr 6, 1999·29 cites·33 claims
- 0884US5244888A5-HT selective agentsABBOTT LAB·Filed 1991·Granted Sep 14, 1993·26 cites·7 claims
- 0974USRE49825EPiperidinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2021·Granted Feb 6, 2024·0 cites·20 claims
- 1073US5792767ABicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted Aug 11, 1998·37 cites·6 claims
- 1171US5288749ATertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitorsABBOTT LAB·Filed 1991·Granted Feb 22, 1994·26 cites·13 claims
- 1270US5597823ATricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted Jan 28, 1997·31 cites·17 claims
- 1369US5521181ABicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted May 28, 1996·15 cites·20 claims
- 1465US6166019APiperazinyl pyrimidine dione compounds selective for adrenoceptorsABBOTT LAB·Filed 1999·Granted Dec 26, 2000·16 cites·5 claims
- 1562US10112924B2Piperdinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2016·Granted Oct 30, 2018·0 cites·19 claims
- 1656US7265115B2Diazabicyclic CNS active agentsABBOTT LAB·Filed 2003·Granted Sep 4, 2007·1 cites·14 claims
- 1749US2011065685A1Novel indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2010·Application pending·0 cites
- 1848US6133275A3-phenylpyrrolidine alpha-1 adrenergic compoundsABBOTT LAB·Filed 1998·Granted Oct 17, 2000·5 cites·15 claims
- 1945US6503935B1Imidazoles and related compounds as α1A agonistsABBOTT LAB·Filed 1999·Granted Jan 7, 2003·5 cites·6 claims
- 2045US6153614APiperazinyl pyrimidine dione compounds selective for adrenoceptorsABBOTT LAB·Filed 1998·Granted Nov 28, 2000·6 cites·31 claims
- 2145US2007184490A1Neuronal nicotinic receptor ligands and their useVERLINDEN MARLEEN·Filed 2007·Application pending·0 cites
- 2240US8906911B2Chemokine receptor antagonistsABBVIE INC·Filed 2013·Granted Dec 9, 2014·0 cites·21 claims
- 2339US2003073850A14-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their useFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael D. Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →